Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Solanezumab [INN]
RN: 955085-14-0
UNII: 5D6PWO0333

Note

  • A humanized anti-beta-amyloid monoclonal antibody.

Molecular Formula

  • C6408-H9944-N1716-O1998-S42
 

Classification Code

  • Alzheimers Disease
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Solanezumab [INN]

Synonyms

  • A4 [Clinical Trial]
  • Immunoglobulin G1, anti-(human amyloid beta A4 protein); humanized mouse monoclonal LY2062430 des-omega-lysine-gamma1 heavy chain (215-219')-disulfide with humanized mouse monoclonal LY2062430 kappa light chain (221-221'':224-224'')- bisdisulfide dimer
  • Immunoglobulin G1, anti-(human beta-amyloid peptide) (humanized monoclonal LY2062430 heavy chain, disulfide with humanized monoclonal LY2062430 light chain, dimer)
  • LY 2062430
  • LY-2062430
  • LY2062430
  • Solanezumab
  • UNII-5D6PWO0333

Systematic Name

  • Immunoglobulin G1, anti-(human beta-amyloid) (human-mouse monoclonal LY2062430 heavy chain), disulfide with human-mouse monoclonal LY2062430 light chain, dimer

Registry Numbers

CAS Registry Number

  • 955085-14-0

FDA UNII

  • 5D6PWO0333

System Generated Number

  • 0955085140